High levels in serum, but no signs of intrathecal synthesis of anti- sulfatide antibodies in HIV-1 infected individuals with or without central nervous system complications

Journal of Neuroimmunology

Volumn 94, Issue 1-2, 1999, Pages 153-156

  Gisslén, Magnus ^a   Lekman, Annika ^b   Fredman, Pam ^b  

^a Institute of Laboratory Medicine   (Sweden)

^b Institute of Clinical Neuroscience   (Sweden)

Author keywords

Anti sulfatide antibodies; Cerebrospinal fluid; HIV; Serum

Indexed keywords

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; BRAIN DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DEMENTIA; DEMYELINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AIDS DEMENTIA COMPLEX; AUTOANTIBODIES; HIV-1; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; MYELIN SHEATH; SULFOGLYCOSPHINGOLIPIDS;

EID: 0033081927     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00244-6     Document Type: Article

References (29)

1. American Academy of Neurology AIDS Task Force Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology. 41:1991;778-785.
2. Budka H. Neuropathology of HIV infection. Brain Pathol. 1:1991;163-175.
3. Buschard K., Josefsen K., Horn T., Fredman P. Sulphatide and sulphatide antibodies in insulin-dependent diabetes mellitus. Lancet. 342:1993;840.
4. CDC, 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb. Mortal Wkly. Rep. 41, RR-17.
5. de Gasperi R., Gama Sosa M.A., Patarca R., Battistini S., Lamoreux M.R., Raghavan S., Kowall N.W., Harrington Smith K., Fletcher M.A., Kolodny E.H. Intrathecal synthesis of anti-sulfatide IgG is associated with peripheral nerve disease in acquired immunodeficiency syndrome. AIDS Res. Hum. Retroviruses. 12:1996;205-211.
6. de la Monte S.M., Ho D.D., Schooley R.T., Hirsch M.S., Richardson E.P. Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection. Neurology. 37:1987;562-569.
7. Dunlop O., Björklund R., Abdelnoor M., Myrvang B. Total reaction time: a new approach in early HIV encephalopathy? Acta Neurol. Scand. 88:1993;344-348.
8. Fredman P. The role of anti-glycolipid antibodies in neurological disorders. Ann. New York Acad. Sci. 845:1998;341-352.
9. Fredman P., Lekman A. Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disorders. Neurochem. Res. 22:1997;1071-1083.
10. Fredman P., Vedeler C.A., Nyland H., Aarli J.A., Svennerholm L. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin. J. Neurol. 238:1991;75-79.
11. Gama Sosa M.A., De Gasperi R., Patarca R., Fletcher M.A., Kolodny E.H. Antisulfatide IgG antibodies recognize HIV proteins. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15:1997;83-84. [letter].
12. Gisslén M., Chiodi F., Fuchs D., Norkrans G., Svennerholm B., Wachter H., Hagberg L. Markers of immune stimulation in the cerebrospinal fluid during HIV infection: A longitudinal study. Scand. J. Infect. Dis. 26:1994;523-533.
13. Gisslén M., Fredman P., Norkrans G., Hagberg L. Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type 1 infection. AIDS Res. Hum. Retroviruses. 12:1996;149-155.
14. Hagberg L., Norkrans G., Zanetta J.P., Lehmann S., Bergstrom T. Cerebrospinal fluid anti-cerebellar soluble lectin antibodies in human immunodeficiency virus type 1 infection. J. Neuroimmunol. 36:1992;245-249.
15. Karlsen N., Reinvang I., Fröland S. Slowed reaction time in asymptomatic HIV-positive patients. Acta Neurol. Scand. 86:1992;242-246.
16. Laurell C.-B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal. Biochem. 15:1966;45-52.
17. Li F., Pestronk A., Griffin J., Feldman E.L., Cornblath D., Trotter J., Zhu S., Yee W.C., Phillips D., Peeples D.M., Winslow B. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology. 41:1991;357-362.
18. Mastroianni C.M., Liuzzi G.M., Vullo V., Jirillo E., Delia S., Riccio P. Detection of cerebrospinal fluid antibodies against myelin basic protein in patients with AIDS dementia complex. Mol. Chem. Neuropathol. 14:1991;227-236.
19. Molander M., Berthold C.H., Persson H., Andersson K., Fredman P. Monosialoganglioside (GM1) immunofluorescence in rat spinal roots studied with a monoclonal antibody. J. Neurocytol. 26:1997;101-111.
20. Navia B., Cho E.-S., Petito C., Price R. The AIDS dementia complex: II. Neuropathology. Ann. Neurol. 19:1986;525-535.
21. Navia B., Jordan B., Price R. The AIDS dementia complex: I. Clinical features. Ann. Neurol. 19:1986;517-524.
22. Norton W.T., Autilio L.A. The lipid composition of purified bovine brain myelin. J. Neurochem. 13:1966;213-222.
23. Price R.W., Brew B.J. The AIDS dementia complex. J. Infect. Dis. 158:1988;1079-1083.
24. Raff M.C., Fields K.L., Hakomori S.I., Mirsky R., Pruss R.M., Winter J. Cell-type-specific markers for distinguishing and studying neurons and the major classes of glia cells in culture. Brain Res. 174:1979;283-308.
25. Ryberg B. Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy. J. Neurol. Sci. 38:1978;357-382.
26. Solinger A.M., Hess E.V. Induction of autoantibodies by human immunodeficiency virus infection and their significance. Rheum. Dis. Clin. North Am. 17:1991;157-176.
27. Tibbling G., Link H., Öhman S. Principles of albumin and IgG analyses in neurological disorders: I. Establishment of reference values. Scand. J. Clin. Lab. Invest. 37:1977;385-390.
28. van den Berg L.H., Lankamp C.L., de Jager A.E., Notermans N.C., Sodaar P., Marrink J., de Jong H.J., Bar P.R., Wokke J.H. Anti-sulphatide antibodies in peripheral neuropathy. J. Neurol. Neurosurg. Psychiatry. 56:1993;1164-1168.
29. Wikkelsö C., Andersson M., Andersson R., Blomstrand C. Isoelectric focusing followed by silver staining. A suitable method for routine investigation of cerebrospinal fluid proteins. Eur. Neurol. 23:1984;306-312.